论文部分内容阅读
肝性脑病各种治疗方法的风险和效益各有不同。非吸收性双糖和新霉素由于疗效不确定,而且有常见的剂量限制性副作用,使其应用受到限制。利福昔明(rifaximin)对肝性脑病
Hepatic encephalopathy treatment of various risks and benefits vary. Nonabsorbable disaccharides and neomycin are limited in their use due to their uncertain efficacy and their common dose-limiting side effects. Rifaximin on Hepatic Encephalopathy